Optometry will change preventive medicine?

A

AdminWolf

Guest
ABSTRACT:
Vague black/ white X-Ray angiographic atherosclerosis shadows compare badly for cost/ relevance with photomicrographically clear, coloured, retinal arterial plaque images.

Accepted as accurate surrogate indicators of correspondingly stressed coronary target vessels, cerebrostriate and non-expansile kidney vasculature, three sequential images over 6 months, of nutritionally reversible plaque are powerfully pathognomonic of increasing/decreasing heart attack risk - a paradigm shift in public health management, impossible with X-Rays.

Whilst treating and preventing contact lens related giant papillary conjunctivitis, hyperaemia and ‘dry eye’ with gram dose ascorbate (VC) author SB serendipitously discovered completely unanticipated plaque disappearances (retolysis) papillary and retinal reperfusion, reported hypertension cure, freedom from illness, asthma and more.

This refutes the received medical wisdom that (1) atherosclerosis is irreversible and (2) that double blind placebo controlled trials are needed to prove vitamin C mediated retolysis. Completely unanticipated VC mediated retolysis cannot, by definition, be labelled “placebo effect;” nor can hundreds of images showing consistent progressive 10 years long retolysis be “anecdotal.”

The examination was termed Cardioretinometry®; the intervention process Nutritional Prophylactic CardioRetinometry® (NPCret).

METHOD: A representative series of images from SB’s practice are presented with more on www.cardioretinometry.com. 35 sequentially modifiable retinal features update a grading scale that is half finished before the coronary angiography scale begins, ending occlusive heart disease with atherolytic formulae following Pauling/Rath principles.

RESULTS: 150 testimonials since 2006 describe mostly 10 years of retolysis, often claimed as wholly VC dependent following instruction in the therapeutic principle subsequent to the first (December 2002) press announcement after 3 years of secret research and observations following the 1999 discovery.

Before this, and ethically debatable, patients were kept deliberately uninformed in order to gather proof of the non-placebo related retolysis. NPCRet supports Pauling/Rath and histamine - monocyte adhesion theories of cardiovascular disease and Levy’s 2006 book, 650 scurvy related citations proving the CHD link. NPCRet is recognised in Hickey and Roberts 2006 “RDA” book and journals as a “third quantifiable scurvy biomarker” and Fonorow’s May 2008 book. Revealing >95% of retinae atherosclerotic, NPCRet exceeds electron beam tomography’s sensitivity as a 98% sensitive CHD indicator; 95% specific for its absence;

CONCLUSION: 150 years after Helmholtz,’ his most valuable ophthalmoscope application beckons. Although lacking megapixels, 1998 cameras reveal dramatic curvilinear and ischaemic scorbutic changes. Urgent evaluation of statin/antioxidant treatments is recommended to end obstructive/haemorrhagic cardiovascular disease. Without sequential knowledge, of microscopic plaque progression or regression unavailable by X-rays, current cardiology advice, is now seen to be reckless and inappropriate re heart attack and thrombosis risk.


ABOUT THE AUTHOR:
Dr. Sydney J. Bush DOpt. (IOSc. London) PhD
Dir. Institute of CardioRetinometry
Paragon St (Arcade Corner) Hull England.HU1 3PQ.
CardioRetinometry (Reg. EEC) (Reg U.S. Pat+)
'Before and After' images and patients' unconditional
testimonials attribute 10 yrs successful Cardiovascular Disease
Reversals to improved Nutrition, Lifestyle, Vit. C and/or
Antioxidants suggesting an average 15 yrs Life Extension.
Tel: 0044(0)1482-223131 Fax 0044 (0) 1482-227636
E-Mail: cardioretinometry@sydneybush.co.uk
 
Last edited by a moderator: